Importance of Genetic Testing in Dilated Cardiomyopathy: Applications and Challenges in Clinical Practice
- PMID: 31483024
- PMCID: PMC6777894
- DOI: 10.5935/abc.20190144
Importance of Genetic Testing in Dilated Cardiomyopathy: Applications and Challenges in Clinical Practice
Abstract
Dilated cardiomyopathy (DCM) is a clinical syndrome characterized by left ventricular dilatation and contractile dysfunction. It is the most common cause of heart failure in young adults. The advent of next-generation sequencing has contributed to the discovery of a large amount of genomic data related to DCM. Mutations involving genes that encode cytoskeletal proteins, the sarcomere, and ion channels account for approximately 40% of cases previously classified as idiopathic DCM. In this scenario, geneticists and cardiovascular genetics specialists have begun to work together, building knowledge and establishing more accurate diagnoses. However, proper interpretation of genetic results is essential and multidisciplinary teams dedicated to the management and analysis of the obtained information should be considered. In this review, we approach genetic factors associated with DCM and their prognostic relevance and discuss how the use of genetic testing, when well recommended, can help cardiologists in the decision-making process.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
Targeted next-generation sequencing of candidate genes reveals novel mutations in patients with dilated cardiomyopathy.Int J Mol Med. 2015 Dec;36(6):1479-86. doi: 10.3892/ijmm.2015.2361. Epub 2015 Oct 7. Int J Mol Med. 2015. PMID: 26458567 Free PMC article.
-
Dilated cardiomyopathy: a new insight into the rare but common cause of heart failure.Heart Fail Rev. 2022 Mar;27(2):431-454. doi: 10.1007/s10741-021-10125-6. Epub 2021 Jul 10. Heart Fail Rev. 2022. PMID: 34245424 Review.
-
Familial dilated cardiomyopathy. Clinical and genetic characteristics.Herz. 2012 Dec;37(8):822-9. doi: 10.1007/s00059-012-3707-9. Herz. 2012. PMID: 23223770
-
Evidence-Based Assessment of Genes in Dilated Cardiomyopathy.Circulation. 2021 Jul 6;144(1):7-19. doi: 10.1161/CIRCULATIONAHA.120.053033. Epub 2021 May 5. Circulation. 2021. PMID: 33947203 Free PMC article.
-
Current perspectives on the diagnosis and management of dilated cardiomyopathy Beyond heart failure: a Cardiomyopathy Clinic Doctor's point of view.Hellenic J Cardiol. 2018 Sep-Oct;59(5):254-261. doi: 10.1016/j.hjc.2018.05.008. Epub 2018 May 25. Hellenic J Cardiol. 2018. PMID: 29807197 Review.
Cited by
-
Disease Modeling and Disease Gene Discovery in Cardiomyopathies: A Molecular Study of Induced Pluripotent Stem Cell Generated Cardiomyocytes.Int J Mol Sci. 2021 Mar 24;22(7):3311. doi: 10.3390/ijms22073311. Int J Mol Sci. 2021. PMID: 33805011 Free PMC article.
-
The Role of Genetics in Risk Stratification Strategy of Dilated Cardiomyopathy.Rev Cardiovasc Med. 2022 Sep 9;23(9):305. doi: 10.31083/j.rcm2309305. eCollection 2022 Sep. Rev Cardiovasc Med. 2022. PMID: 39077708 Free PMC article. Review.
References
-
- Weber R, Kantor P, Chitayat D, Friedberg MK, Golding F, Mertens L, et al. Spectrum and outcome of primary cardiomyopathies diagnosed during fetal life. JACC Heart Fail. 2014;2(4):403–411. - PubMed
-
- Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016 Jun 14;37(23):1850–1858. - PubMed
-
- Bakalakos A, Ritsatos K, Anastasakis A. Current perspectives on the diagnosis and management of dilated cardiomyopathy Beyond heart failure: a Cardiomyopathy Clinic Doctor’s point of view. Hellenic J Cardiol. 2018 May 25; - PubMed
-
- Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013;10(9):531–547. - PubMed
-
- Dadson K, Hauck L, Billia F. Molecular mechanisms in cardiomyopathy. Clin Sci (Lond) 2017;131(13):1375–1392. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical